Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, manufactures, and commercializes medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry. Valued at $30.5 billion by market cap, the company also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics.
Shares of this world's leading animal health company have notably underperformed the broader market over the past year. ZTS has declined 50.4% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 22.4%. In 2026, ZTS stock is down 41.9%, compared to the SPX's 13.3% rise on a YTD basis.
Don't ***** ume Micron Will Share SanDisk's Fate. Here's Why.
The Nvidia-SpaceX Deal Is Sending a Clear Signal on AI Dominance
Rocket Lab Investors Have Plenty to Cheer Ahead of Q2 Earnings Today
#market
Shares of this world's leading animal health company have notably underperformed the broader market over the past year. ZTS has declined 50.4% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 22.4%. In 2026, ZTS stock is down 41.9%, compared to the SPX's 13.3% rise on a YTD basis.
Don't ***** ume Micron Will Share SanDisk's Fate. Here's Why.
The Nvidia-SpaceX Deal Is Sending a Clear Signal on AI Dominance
Rocket Lab Investors Have Plenty to Cheer Ahead of Q2 Earnings Today
#market
15 days ago
